Condition
Immune Checkpoint Inhibitors (ICIs) clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Immune Checkpoint Inhibitors (ICIs) clinical trials that are recruiting, in China. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest Immune Checkpoint Inhibitors (ICIs) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Emotional stress and immunotherapy outcomes in liver cancer | — | Zhanjiang, Guangdong and 4 other locations | Recruiting | Aug 26, 2025 |
| ctDNA‑MRD guided Ivonescimab plus docetaxel versus standard care for advanced NSCLC after long immunotherapy benefit | Phase 2 | Changsha and 19 other locations | Recruiting | Apr 30, 2025 |
| Predicting thrombosis risk in lung cancer patients on immune therapy | — | Zhengzhou, Henan and 4 other locations | Recruiting | Apr 30, 2025 |
| Neoantigen vaccines for treating esophageal cancer | Phase 2 | Chengdu, Please Select | Recruiting | Nov 5, 2024 |
All recruiting trials (4)
-
Emotional stress and immunotherapy outcomes in liver cancer
This study will see if emotional distress changes how well immunotherapy works for people with hepatocellular carcinoma.
-
ctDNA‑MRD guided Ivonescimab plus docetaxel versus standard care for advanced NSCLC after long immunotherapy benefit
This trial tests whether adding Ivonescimab with docetaxel, guided by ctDNA minimal residual disease (MRD), can help people with advanced NSCLC who had a long benefit from first‑line immunotherapy but are now MRD‑positive.
-
Predicting thrombosis risk in lung cancer patients on immune therapy
This study is trying to see if certain factors can help predict the risk of blood clots in lung cancer patients receiving immune therapy.
-
Neoantigen vaccines for treating esophageal cancer
This study is testing a new vaccine for people with advanced esophageal cancer to see if it can help them live longer and feel better after their treatment.
Related topics
Quick answers
How many Immune Checkpoint Inhibitors (ICIs) clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.